Moteur de recherche d’entreprises européennes

Financement de l’UE (10,6 M €) : Qualité de vie en oncologie : mesurer ce qui compte pour les patients atteints de cancer et les survivants du cancer en Europe Hor29/12/2022 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

Qualité de vie en oncologie : mesurer ce qui compte pour les patients atteints de cancer et les survivants du cancer en Europe

EUonQoL aims to develop, pilot and validate the EUonQoL-Kit, a patient-driven, unified system for the assessment of quality of life (QoL) based on evaluations and preferences of cancer patients and survivors. The EUonQoL-Kit will be developed from a patient perspective, administered digitally, available in the EU27 and Associated countries languages, and applicable in future, periodic surveys to contribute to the EU’s mission on cancer. At the core of the EUonQoL there is the adoption of a multistakeholder, co-design methodology, engaging patient representatives, healthcare professionals, administrators, policymakers, and citizens in all project related activities. Existing QoL tools will be reviewed, scoping all relevant sources. This review will be used in the context of the codesign consensus with stakeholders’ and patients’ preferences to identify gaps and establish all QoL dimensions that are relevant from the perspectives of patients, clinicians, and society. A multidisciplinary panel of leading experts will develop the EUonQoL-Kit to be validated in a digital pilot survey of 4,000 patients and survivors enrolled through a network of EU cancer centres. An analysis of factors potentially impacting QoL, will also be performed. EUonQoL will explore strategies for the implementation and exploitation of the EUonQoL-Kit, while coordinating a QoL-Patient-Centred Care (PCC) cluster across Cancer Mission projects to develop a system-wide PCC policy, built on sustained stakeholder engagement and targeted outreach, as the basis for routine QoL data collection. EUonQoL is composed of research institutions, cancer centres, as well as scientific, professional, and patient representative organizations involved in cancer research, all with extensive experience and robust scientific background in developing self-reported QoL measures. This partnership fuels the ambition of EUonQoL to translate QoL data into future changes in cancer care policy and clinical practice.


The Leeds Teaching Hospitals National Health Service Trust ?
Alleanza Contro IL Cancro 0,00 €
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG 246 000 €
Digital Institute for Cancer Outcomes Research 589 653 €
European Association for Palliative Care 101 541 €
European Cancer Organisation 485 375 €
European Organisation for Research AND Treatment OF Cancer Aisbl 583 000 €
Federatia Asociatiilor Bolnavilor de Cancer 31 750 €
Federazione Italiana Delle Associazioni Di Volontariato IN Oncologia 127 375 €
Fondazione Irccs Istituto Nazionale DEI Tumori 2 026 789 €
Fundacio Institut Hospital del Mar D Investigacions Mediques 462 099 €
Institut Curie 152 143 €
Institut Gustave Roussy 288 625 €
Istituti Fisioterapici Ospitalieri 0,00 €
Istituto Europeo Di Oncologia Srl 703 900 €
ISTITUTO NAZIONALE TUMORI Fondazione Pascale 0,00 €
Medizinische Universitat Innsbruck 141 750 €
Organisation OF European Cancer Institutes 1 694 340 €
Oslo Universitetssykehus HF 749 375 €
Region Hovedstaden 616 584 €
Sdruzhenie Asotsiatsia NA Patsientite S Onkologichni Zabolyavania I Priyateli 31 750 €
SPOREDATA OÜ 145 831 €
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS 172 896 €
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG 859 801 €
Unicancer 198 938 €
Universita Degli Studi Di Milano 197 796 €

https://cordis.europa.eu/project/id/101096362

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : The Leeds Teaching Hospitals National Health Service Trust, Leeds, Royaume Uni.